Cuprina (Cayman) Limited (CUPR)
NasdaqCM: CUPR
· Echtzeitkurs · USD
2.97
+0.05 (1.71%)
Zum Schluss: Aug 18, 2026, 3:57 PM
Cuprina (Cayman) Limited (CUPR) Stock Price, Analysis & Data
1.71% (1D)
| Geld | n/a |
| Marktkapitalisierung | 7.96 Mio |
| Umsatz (TTM) | 49.89K |
| Nettogewinn (TTM) | -4.67 Mio |
| Beta | n/a |
| EPS (ttm) | -1.45 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 2.00 |
| KUV (TTM) | 159.60 |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 11,469 |
| Ø Vol. (20D) | 3,138,943 |
| Eröffnung | 2.82 |
| Vortagesschluss | 2.92 |
| Tagesspanne | 2.72 - 3.02 |
| 52-Wk Range | 1.76 - 19.60 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über CUPR
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hyd...
Branche Medical Instruments & Supplies
Sektor Healthcare
IPO Datum Apr 10, 2025
Mitarbeiter 10
Börse NasdaqCM
Tickersymbol CUPR
Website https://www.cuprina.com.sg
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Cuprina (Cayman) 49.89K, ein Anstieg von 3.26% im Vergleich zum Vorjahr (48.32K). Der Gewinn lag bei -4.67 Mio, ein Anstieg von 199.48 %.
Finanzberichte